890 related articles for article (PubMed ID: 32315713)
1. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination.
Gorter RP; Baron W
Neurosci Lett; 2020 Jun; 729():134980. PubMed ID: 32315713
[TBL] [Abstract][Full Text] [Related]
2. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
3. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
Unal DB; Caliari SR; Lampe KJ
Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
[TBL] [Abstract][Full Text] [Related]
4. The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury.
Duncan GJ; Manesh SB; Hilton BJ; Assinck P; Plemel JR; Tetzlaff W
Glia; 2020 Feb; 68(2):227-245. PubMed ID: 31433109
[TBL] [Abstract][Full Text] [Related]
5. Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Zhao C; Ma D; Zawadzka M; Fancy SP; Elis-Williams L; Bouvier G; Stockley JH; de Castro GM; Wang B; Jacobs S; Casaccia P; Franklin RJ
J Neurosci; 2015 Aug; 35(33):11482-99. PubMed ID: 26290228
[TBL] [Abstract][Full Text] [Related]
6. Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?
Pukos N; Goodus MT; Sahinkaya FR; McTigue DM
Glia; 2019 Nov; 67(11):2178-2202. PubMed ID: 31444938
[TBL] [Abstract][Full Text] [Related]
7. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in oligodendrocyte development and remyelination.
Ngo C; Kothary R
J Neurochem; 2022 Aug; 162(4):310-321. PubMed ID: 35536759
[TBL] [Abstract][Full Text] [Related]
9. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
Suo N; He B; Cui S; Yang Y; Wang M; Yuan Q; Xie X
Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
[TBL] [Abstract][Full Text] [Related]
10. Demyelinating processes in aging and stroke in the central nervous system and the prospect of treatment strategy.
Chen D; Huang Y; Shi Z; Li J; Zhang Y; Wang K; Smith AD; Gong Y; Gao Y
CNS Neurosci Ther; 2020 Dec; 26(12):1219-1229. PubMed ID: 33210839
[TBL] [Abstract][Full Text] [Related]
11. Conditional Deletion of the L-Type Calcium Channel Cav1.2 in NG2-Positive Cells Impairs Remyelination in Mice.
Santiago González DA; Cheli VT; Zamora NN; Lama TN; Spreuer V; Murphy GG; Paez PM
J Neurosci; 2017 Oct; 37(42):10038-10051. PubMed ID: 28899915
[TBL] [Abstract][Full Text] [Related]
12. The fatty acid binding protein FABP7 is required for optimal oligodendrocyte differentiation during myelination but not during remyelination.
Foerster S; Guzman de la Fuente A; Kagawa Y; Bartels T; Owada Y; Franklin RJM
Glia; 2020 Jul; 68(7):1410-1420. PubMed ID: 32017258
[TBL] [Abstract][Full Text] [Related]
13. Impaired Postnatal Myelination in a Conditional Knockout Mouse for the Ferritin Heavy Chain in Oligodendroglial Cells.
Wan R; Cheli VT; Santiago-González DA; Rosenblum SL; Wan Q; Paez PM
J Neurosci; 2020 Sep; 40(40):7609-7624. PubMed ID: 32868463
[TBL] [Abstract][Full Text] [Related]
14. A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.
Su W; Matsumoto S; Banine F; Srivastava T; Dean J; Foster S; Pham P; Hammond B; Peters A; Girish KS; Rangappa KS; Basappa ; Jose J; Hennebold JD; Murphy MJ; Bennett-Toomey J; Back SA; Sherman LS
Glia; 2020 Feb; 68(2):263-279. PubMed ID: 31490574
[TBL] [Abstract][Full Text] [Related]
15. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
16. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
Tepavčević V; Lubetzki C
Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
[TBL] [Abstract][Full Text] [Related]
17. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.
Talbott JF; Loy DN; Liu Y; Qiu MS; Bunge MB; Rao MS; Whittemore SR
Exp Neurol; 2005 Mar; 192(1):11-24. PubMed ID: 15698615
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the Genetic Crosstalk between Microglia and Oligodendrocyte Precursor Cells during Demyelination and Remyelination Using Transcriptomic Data.
Enrich-Bengoa J; Manich G; Dégano IR; Perálvarez-Marín A
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499195
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination.
Galloway DA; Gowing E; Setayeshgar S; Kothary R
Glia; 2020 May; 68(5):859-877. PubMed ID: 31441132
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Skaper SD
Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
